Wordt geladen...
ASCO 2018 highlights: metastatic breast cancer
This article reviews the clinically most relevant presentations at the American Society of Clinical Oncology (ASCO) annual meeting 2018 on the topic of metastatic breast cancer. In the randomized placebo-controlled phase 3 trial MONALEESA-3, testing ribociclib vs. placebo in combination with fulvest...
Bewaard in:
| Gepubliceerd in: | Memo |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer Vienna
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6280779/ https://ncbi.nlm.nih.gov/pubmed/30595753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12254-018-0450-9 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|